Prof Emma Duncan is Professor of Clinical Endocrinology, King’s College London, and Honorary Consultant Physician at Guy’s and St Thomas’ NHS Foundation Trust.
Since her undergraduate days, she has been fascinated by endocrinology and the skeleton. Her research spans the genetics of many endocrine disorders, from common variant to rare monogenic diseases, publishing multiple high-impact papers interrogating the genetics of osteoporosis and skeletal dysplasias, MODY [maturity-onset diabetes of the young], and phaeochromocytomas and paragangliomas. Prof Duncan’s practical experience in gene mapping includes genetic epidemiology, linkage, genome-wide association studies, and massively parallel sequencing (MPS) technologies; and she has played a pioneering role in the translation of genetic technologies (such as high-throughput microarray genotyping and massively parallel sequencing) into clinical practice.
Prof Duncan has also published multiple clinical research papers in bone and other endocrine disorders. Recently, she has contributed to COVID-19 research, particularly COVID-19 in children; and she co-leads the KCL COVID Symptom Study Biobank with particular focus on interrogating the genetics of the post-COVID syndrome.
Prof Duncan practises medicine as a consultant physician and specialist in endocrinology, with special interest in bone and neuroendocrine disease. She contributes to leadership and governance nationally and internationally, previously serving as President of the Australian and New Zealand Bone and Mineral Society, and currently serving as Councillor for the American Society for Bone and Mineral Research and Associate Editor of the Journal for Bone and Mineral Research and Endocrine Reviews.